九洲药业前三季度净利7.48亿元，同比增长18.51%

Core Viewpoint - Jiuzhou Pharmaceutical (603456) reported a revenue of approximately 4.16 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 4.92% and a net profit attributable to shareholders of 748 million yuan, which represents an 18.51% increase year-on-year [1] Financial Performance - The company's revenue for the first three quarters reached about 4.16 billion yuan, marking a 4.92% increase compared to the same period last year [1] - The net profit attributable to shareholders was 748 million yuan, showing an 18.51% year-on-year growth [1] Factors Influencing Performance - The increase in net profit during the reporting period is primarily attributed to the growth in sales and an increase in product gross margins [1]